N-acetylated, C-terminal amidated variant of Semax with longer duration.
Chemical modifications (N-terminal acetylation and C-terminal amidation) protect the Semax peptide from peptidase cleavage, extending duration vs base Semax.
Evidence summary in progress. See the citations section below for the underlying research papers.
No FDA label or editorial side-effect profile is on file for this compound yet. See the clinical trials and citations sections for study-reported safety data.
No documented drug interactions on file.
Not FDA approved. Research chemical in US.
Not available via 503A/503B compounding pharmacies.
Regulatory data last verified 4/19/2026
No indexed ClinicalTrials.gov studies for N-Acetyl Semax Amidate. This usually means the compound isn't being studied under an IND — check the citations section for peer-reviewed research instead.
No citations indexed yet.